BIOTRICITY INC. Interest Expense
BIOTRICITY INC. (BTCY) reported Interest Expense of $849.54 thousand for the 3-month period ending 2024-12-31, per its 10-Q/A filed 2025-02-20.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2026-02-11
- BIOTRICITY INC. interest expense for the quarter ending 2024-12-31 was $849.54K, a 7.53% increase year-over-year.
- BIOTRICITY INC. interest expense for the quarter ending 2024-09-30 was $752.08K, a 0.16% decline year-over-year.
- BIOTRICITY INC. interest expense for the quarter ending 2024-06-30 was $768.67K, a 16.38% increase year-over-year.
- BIOTRICITY INC. interest expense for the quarter ending 2024-03-31 was $814.94K, a 28.58% increase year-over-year.
- BIOTRICITY INC. interest expense for fiscal 2024 was $3.02M, a 64.14% increase from fiscal 2023.
- BIOTRICITY INC. interest expense for fiscal 2023 was $1.84M, a 43.28% increase from fiscal 2022.
- BIOTRICITY INC. interest expense for fiscal 2022 was $1.28M.
| Period end | Interest Expense 1 month | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|---|
| 2024-12-31 | $849.54K 10-Q/A · filed 2025-02-20 | $1.60M derived: sum of 2 quarters · filed 2025-02-20 | $2.37M 10-Q/A · filed 2025-02-20 | $3.19M derived: sum of 4 quarters · filed 2025-02-20 | ||
| 2024-09-30 | $752.08K 10-Q · filed 2024-11-14 | $1.52M 10-Q · filed 2024-11-14 | $2.34M derived: sum of 3 quarters · filed 2024-11-14 | $3.13M derived: sum of 4 quarters · filed 2025-02-20 | ||
| 2024-06-30 | $768.67K 10-Q · filed 2024-08-19 | $1.58M derived: sum of 2 quarters · filed 2024-08-19 | $2.37M derived: sum of 3 quarters · filed 2025-02-20 | $3.13M derived: sum of 4 quarters · filed 2025-02-20 | ||
| 2024-03-31 | $814.94K derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-06-27 | $1.61M derived: sum of 2 quarters · filed 2025-02-20 | $2.36M derived: sum of 3 quarters · filed 2025-02-20 | $3.02M 10-K · filed 2024-06-27 | ||
| 2023-12-31 | $790.08K 10-Q/A · filed 2025-02-20 | $1.54M derived: sum of 2 quarters · filed 2025-02-20 | $2.20M 10-Q/A · filed 2025-02-20 | $2.84M derived: sum of 4 quarters · filed 2025-02-20 | ||
| 2023-09-30 | $753.27K 10-Q · filed 2024-11-14 | $1.41M 10-Q · filed 2024-11-14 | $2.05M derived: sum of 3 quarters · filed 2024-11-14 | $2.46M derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | $660.51K 10-Q · filed 2024-08-19 | $1.29M derived: sum of 2 quarters · filed 2024-08-19 | $1.71M derived: sum of 3 quarters · filed 2024-08-19 | $2.11M derived: sum of 4 quarters · filed 2024-08-19 | ||
| 2023-03-31 | $633.82K derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-27 | $1.05M derived: sum of 2 quarters · filed 2024-06-27 | $1.45M derived: sum of 3 quarters · filed 2024-06-27 | $1.84M 10-K · filed 2024-06-27 | ||
| 2022-12-31 | $413.40K 10-Q · filed 2024-02-20 | $816.95K derived: sum of 2 quarters · filed 2024-02-20 | $1.21M 10-Q · filed 2024-02-20 | |||
| 2022-11-30 | $364.00K 10-Q · filed 2026-02-11 | |||||
| 2022-09-30 | $403.55K 10-Q · filed 2023-11-14 | $791.94K 10-Q · filed 2023-11-14 | ||||
| 2022-06-30 | $388.39K 10-Q · filed 2023-08-14 | |||||
| 2022-03-31 | $1.28M 10-K · filed 2023-06-29 | $379.50K 10-K · filed 2022-07-14 | ||||
| 2021-12-31 | $38.33K 10-Q · filed 2022-02-14 |